Serum uric acid and outcome after acute ischemic stroke: Premier study

Cerebrovascular Diseases

Volumn 35, Issue 2, 2013, Pages 168-174

  Chiquete, Erwin ^a   Ruiz Sandoval, José L ^b   Murillo Bonilla, Luis M ^c   Arauz, Antonio ^d   Orozco Valera, Diego R ^b   Ochoa Guzmán, Ana ^b   Villarreal Careaga, Jorge ^e   León Jiménez, Carolina ^f   Barinagarrementeria, Fernando ^g   Ramos Moreno, Alma ^h   Cantú Brito, Carlos ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^d NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^e Hospital General de Culiacan   (Mexico)

^f Hospital Regional Dr Valentin Gomez Farias   (Mexico)

^g Hospital Angeles Queretaro   (Mexico)

^h Medical Research Area   (Mexico)

Author keywords

Chronic renal disease; Creatinine; Small vessel disease, Mexico; Stroke; Urate; Uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; URIC ACID BLOOD LEVEL; COMPARATIVE STUDY; GENDER; PROSPECTIVE STUDY; RANKIN SCALE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; DISABILITY EVALUATION; FEMALE; HUMANS; HYPERURICEMIA; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; URIC ACID; YOUNG ADULT;

EID: 84874283857     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000346603     Document Type: Article

References (33)

1. Lehto S, Niskanen L, Rönnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29:635-639.
2. Koton S, Howard SC, Warlow CP, Murphy MF, Rothwell PM: Serum urate predicts longterm risk of acute coronary events in women after a transient ischaemic attack and stroke. Cerebrovasc Dis 2008; 26:517-524.
3. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417, 734 men and women in the Apolipo-protein MOrtality RISk study (AMORIS). J Intern Med 2009; 266:558-570.
4. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61:885-892.
5. Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, et al: Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2012; 35:1087-1092.
6. Waring WS: Uric acid: an important antioxi-dant in acute ischaemic stroke. QJM 2002; 95: 691-693.
7. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, et al: Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 2012; 220:525-531.
8. Zhang Z, Bian L, Choi Y: Serum uric Acid: a marker of metabolic syndrome and subclini-cal atherosclerosis in Korean men. Angiology 2012; 63:420-428.
9. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH: Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002; 33:1048-1052.
10. Scherbakov N, Sandek A, Martens-Lobenhof-fer J, Kung T, Turhan G, Liman T, et al: En-dothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke. Cerebrovasc Dis 2012; 33:37-46.
11. Romanos E, Planas AM, Amaro S, Chamorro A: Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 2007; 27:14-20.
12. Hong JM, Bang OY, Chung CS, Joo IS, Gwag BJ, Ovbiagele B: Influence of recanalization on uric acid patterns in acute ischemic stroke. Cerebrovasc Dis 2010; 29:431-439.
13. Brouns R, Wauters A, Van De Vijver G, De Sur-geloose D, Sheorajpanday R, De Deyn PP: Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Clin Chem Lab Med 2010; 48: 383-390.
14. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, et al: Serum uric acid and brain ischemia in normal elderly adults. Neurology 2007; 69:1418-1423.
15. Dawson J, Lees KR, Weir CJ, Quinn T, Ali M, Hennerici MG, et al: Baseline serum urate and 90-day functional outcomes following acute ischemic stroke. Cerebrovasc Dis 2009; 28: 202-203.
16. Kanellis J, Johnson RJ: Editorial comment-Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective. Stroke 2003; 34:1956-1957.
17. Miedema I, Uyttenboogaart M, Koch M, Kremer B, de Keyser J, Luijckx GJ: Lack of association between serum uric acid levels and outcome in acute ischemic stroke. J Neurol Sci 2012; 319:51-55.
18. Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, et al: Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis 2010; 209:215-219.
19. Dimitroula HV, Hatzitolios AI, Karvounis HI: The role of uric acid in stroke: the issue remains unresolved. Neurologist 2008; 14: 238-242.
20. Weir CJ, Muir SW, Walters MR, Lees KR: Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34:1951-1956.
21. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, et al: Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007; 71: 1120-1127.
22. Higgins P, Ferguson LD, Walters MR: Xan-thine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach. Expert Rev Cardiovasc Ther 2011; 9:399-401.
23. Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A: A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke 2007; 38:2173-2175.
24. Amaro S, Cánovas D, Castellanos M, Gállego J, Martí-Fèbregas J, Segura T, Chamorro A: The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute isch-aemic stroke patients within the first 4.5 h of onset of symptoms. Int J Stroke 2010; 5:325-328.
25. Logallo N, Naess H, Idicula TT, Brogger J, Waje-Andreassen U, Thomassen L: Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol 2011; 11:114.
26. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, et al: Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010; 51:641-649.
27. Chiquete E, Cantú-Brito C, Villarreal-Carea-ga J, Murillo-Bonilla LM, Rangel-Guerra R, León-Jiménez C, et al: [Obesity paradox and functional recovery in first-ever acute isch-emic stroke survivors: the PREMIER study]. Rev Neurol 2010; 51:705-713.
28. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, et al: The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demographics, risk factors and outcome. Int J Stroke 2011; 6:93-94.
29. Amaro S, Urra X, Gómez-Choco M, Obach V, Cervera A, Vargas M, et al: Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke 2011; 42(1 suppl):S28-S32.
30. Zhang B, Gao C, Yang N, Zhang W, Song X, Yin J, et al: Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol 2010; 10:82.
31. Nardi K, Milia P: Letter by Nardi and Milia regarding article, 'translational stroke research of the combination of thrombolysis and antioxidant therapy'. Stroke 2011; 42:e547.
32. Poss WB, Huecksteadt TP, Panus PC, Freeman BA, Hoidal JR: Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am J Physiol 1996; 270:L941-L946.
33. George J, Struthers AD: Role of urate, xan-thine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag 2009; 5:265-272.